United States · 
Who invested in Convergent Therapeutics?
Convergent Therapeutics's investors include OrbiMed, RA Capital Management, Novo Holdings and Invus.
United States · Series A startup
Who invested in Convergent Therapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $40MSept 2024
- Investors
- 4
The rounds
- Sept 2024Series A$40M
Source recordedSEC filing: $22M sold, first sale Jul 2024
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Convergent Therapeutics
How much has Convergent Therapeutics raised?
Convergent Therapeutics has raised $40M across 1 round since 2024.
When did Convergent Therapeutics last raise?
Convergent Therapeutics's most recent round was a Series A of $40M in Sept 2024.
What was Convergent Therapeutics's biggest round?
Its most recent round, $40M in Sept 2024, is also its largest on record.
Who backed Convergent Therapeutics first?
Convergent Therapeutics's first round on record, in Sept 2024, was backed by OrbiMed, RA Capital Management and Novo Holdings and 1 others.
What stage is Convergent Therapeutics at?
Convergent Therapeutics's latest named round is a Series A, in Sept 2024.
Where is Convergent Therapeutics based?
Convergent Therapeutics is based in the United States.
Companies like Convergent Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.